BSE Live
Oct 20, 16:01Prev. Close
891.10
Open Price
912.30
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 20, 15:58Prev. Close
889.95
Open Price
885.85
Bid Price (Qty.)
878.40 (11)
Offer Price (Qty.)
0.00 (0)
Balance Sheet of Cohance Lifesciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 25.46 | 25.46 | 25.46 | 25.46 | 25.46 | |
Total Share Capital | 25.46 | 25.46 | 25.46 | 25.46 | 25.46 | |
Reserves and Surplus | 2,290.09 | 2,030.44 | 1,723.92 | 1,495.24 | 1,039.73 | |
Total Reserves and Surplus | 2,290.09 | 2,030.44 | 1,723.92 | 1,495.24 | 1,039.73 | |
Total Shareholders Funds | 2,315.55 | 2,055.90 | 1,749.38 | 1,520.69 | 1,065.18 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 0.00 | 0.00 | 4.56 | 28.44 | 35.59 | |
Deferred Tax Liabilities [Net] | 34.79 | 48.14 | 41.64 | 37.40 | 30.93 | |
Other Long Term Liabilities | 23.94 | 21.24 | 0.70 | 0.46 | 0.74 | |
Long Term Provisions | 0.00 | 10.01 | 7.87 | 8.89 | 6.65 | |
Total Non-Current Liabilities | 58.73 | 79.38 | 54.77 | 75.19 | 73.91 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 70.00 | 38.58 | 64.60 | 67.13 | 105.64 | |
Trade Payables | 71.03 | 41.27 | 61.96 | 105.90 | 82.93 | |
Other Current Liabilities | 57.10 | 20.95 | 23.76 | 31.89 | 28.56 | |
Short Term Provisions | 15.40 | 4.64 | 3.86 | 4.08 | 2.61 | |
Total Current Liabilities | 213.53 | 105.44 | 154.18 | 209.00 | 219.74 | |
Total Capital And Liabilities | 2,587.81 | 2,240.72 | 1,958.33 | 1,804.89 | 1,358.83 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 623.44 | 521.98 | 510.10 | 531.96 | 438.74 | |
Intangible Assets | 61.35 | 1.56 | 1.93 | 2.24 | 2.42 | |
Capital Work-In-Progress | 253.15 | 178.97 | 164.81 | 29.99 | 96.15 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 938.72 | 702.62 | 676.84 | 564.19 | 537.48 | |
Non-Current Investments | 924.64 | 317.21 | 317.21 | 118.67 | 245.65 | |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Loans And Advances | 4.55 | 0.01 | 0.02 | 0.07 | 0.06 | |
Other Non-Current Assets | 11.14 | 11.32 | 9.14 | 13.00 | 10.94 | |
Total Non-Current Assets | 1,879.05 | 1,031.16 | 1,003.21 | 695.93 | 794.13 | |
CURRENT ASSETS | ||||||
Current Investments | 191.56 | 767.45 | 392.85 | 481.22 | 180.59 | |
Inventories | 154.12 | 220.07 | 311.47 | 283.42 | 201.08 | |
Trade Receivables | 242.47 | 126.97 | 109.66 | 236.37 | 102.38 | |
Cash And Cash Equivalents | 22.62 | 21.58 | 46.23 | 32.95 | 9.56 | |
Short Term Loans And Advances | 0.39 | 0.83 | 0.19 | 0.19 | 0.22 | |
OtherCurrentAssets | 97.60 | 72.65 | 94.71 | 74.81 | 70.86 | |
Total Current Assets | 708.76 | 1,209.55 | 955.12 | 1,108.96 | 564.69 | |
Total Assets | 2,587.81 | 2,240.72 | 1,958.33 | 1,804.89 | 1,358.83 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 48.41 | 56.30 | 190.84 | 29.38 | 47.70 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 386.11 | 211.94 | 184.77 | 169.50 | 136.89 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | -- | -- | -- | -- | |
Other Earnings | 1,181.01 | 1,085.67 | 1,467.19 | 1,444.66 | 990.23 | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | 924.64 | 317.21 | 317.21 | 118.67 | 245.65 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | 191.56 | 767.45 | 351.82 | -- | -- | |
Current Investments Unquoted Book Value | -- | -- | 41.03 | 481.22 | 180.59 |
12.06.2025
Cohance Life Standalone March 2025 Net Sales at Rs 330.17 crore, up 35.58% Y-o-Y
04.03.2025
Suven Pharma Consolidated December 2024 Net Sales at Rs 307.15 crore, up 39.73% Y-o-Y
28.11.2024
Suven Pharma Consolidated September 2024 Net Sales at Rs 257.72 crore, up 11.54% Y-o-Y
14.11.2024
Suven Pharma Standalone September 2024 Net Sales at Rs 236.06 crore, up 5.09% Y-o-Y